Corvionis GmbH is a Germany-based life sciences strategy and execution partner supporting biotechnology, advanced therapy, pharmaceutical and medical technology companies in advancing innovation from translational development to early clinical execution and strategic partnerships.
We focus on complex and high-value areas including oncology, hematology, cell and gene therapies, regenerative medicine, radiopharmaceuticals and advanced medical technologies.
Corvionis helps European/Asian and international biotech companies assess clinical development readiness, first-in-human strategy, Phase I/II development logic, regulatory implications and Europe–China collaboration opportunities before key clinical and business development decisions are locked in.
Our work is especially relevant for companies preparing for IND/CTA, first-in-human trials, Phase I/II transition, Europe/China/Asia clinical development optionality, cross-border partnering, licensing, market entry or strategic collaboration.
With medical, clinical development, regulatory, industry partnership and cross-border execution experience across Germany, Europe, China and international markets, Corvionis combines scientific understanding with practical execution.
We help clients identify development risks early, strengthen clinical and partnering narratives, and build actionable strategies for bringing innovative therapies closer to patients.


Corvionis GmbH

Org chart

Teams

Offices

Corvionis GmbH

Org chart

Teams

Offices

Related companies